why choose us

First received: March 15, 2023

Clinical Trial: A Study of CDX-585 in Patients With Advanced Malignancies

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients With Advanced Malignancies

Brief Summary: This is an open-label, non-randomized, multicenter, dose-escalation and expansion study in patients with selected solid tumors.

Read more